Abiopharma

🔍 ALTSCHULLER Susan (Executive)

Company: Climb Bio, Inc. (CLYM)

Report Date: 2026-01-06

Detailed Transactions and Holdings:

• Acquired 142,500 shares of Stock Option (Right to Buy) at $3.81 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2036-01-05 | equity_swap_involved: false | shares_owned_after: 142,500.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This option was granted on January 6, 2026 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through January 6, 2030, subject to the Reporting Person's continued service.